{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:53:59Z","timestamp":1790952839876,"version":"4.1.0"},"reference-count":218,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbcan.2026.189697","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:14:56Z","timestamp":1788221696000},"page":"189697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["B-MYB (MYBL2): from cell cycle regulator to an oncogenic player"],"prefix":"10.1016","volume":"1881","author":[{"given":"Andr\u00e9","family":"Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Mergny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189697_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17071082","article-title":"Exploring the genetic orchestra of cancer: the interplay between oncogenes and tumor-suppressor genes","volume":"17","author":"Singh","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189697_bb0010","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3390\/cancers12082296","article-title":"Transcription factors in cancer development and therapy","volume":"12","author":"Vishnoi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189697_bb0015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.trecan.2025.01.002","article-title":"Oncogenic competence: balancing mutations, cellular state, and microenvironment","volume":"11","author":"Pavinato","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbcan.2026.189697_bb0020","article-title":"Oncogenes and tumor suppressor genes: functions and roles in cancers","volume":"5","author":"Dakal","year":"2024","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.bbcan.2026.189697_bb0025","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/cancers17061008","article-title":"Translational advances in oncogene and tumor-suppressor gene research","volume":"17","author":"Stojchevski","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189697_bb0030","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/molecules23061479","article-title":"Targeting transcription factors for cancer treatment","volume":"23","author":"Lambert","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bbcan.2026.189697_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113885","article-title":"Advances in transcription factor delivery: target selection, engineering strategies, and delivery platforms","volume":"384","author":"Lee","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2026.189697_bb0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.molmed.2020.01.004","article-title":"Transcription factor inhibition: lessons learned and emerging targets","volume":"26","author":"Chen","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189697_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/PPO.0000000000000639","article-title":"Transcription factors and cancer","volume":"29","author":"Shiah","year":"2023","journal-title":"Cancer J."},{"key":"10.1016\/j.bbcan.2026.189697_bb0050","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.scib.2024.03.056","article-title":"Targeting the undruggables\u2014the power of protein degraders","volume":"69","author":"Zhang","year":"2024","journal-title":"Sci. Bull. (Beijing)"},{"key":"10.1016\/j.bbcan.2026.189697_bb0055","series-title":"Targeting Transcription Factors in Cancer: From \u201cUndruggable\u201d to \u201cDruggable\u201d","first-page":"107","author":"Tao","year":"2023"},{"key":"10.1016\/j.bbcan.2026.189697_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semcancer.2023.12.001","article-title":"Deregulated transcription factors in the emerging cancer hallmarks","volume":"98","author":"Hasan","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-023-10153-8","article-title":"From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies","volume":"43","author":"Anand","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2026.189697_bb0070","article-title":"Emerging role of MYB transcription factors in cancer drug resistance","volume":"7","author":"Biersack","year":"2024","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.bbcan.2026.189697_bb0075","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1073\/pnas.1808136115","article-title":"Structural mechanism of Myb\u2013MuvB assembly","volume":"115","author":"Guiley","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1534\/genetics.104.034132","article-title":"Functional evolution of the vertebrate Myb gene family","volume":"169","author":"Davidson","year":"2005","journal-title":"Genetics"},{"key":"10.1016\/j.bbcan.2026.189697_bb0085","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0092-8674(83)90416-6","article-title":"The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb","volume":"33","author":"Klempnauer","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189697_bb0090","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0092-8674(82)90138-6","article-title":"Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene","volume":"31","author":"Klempnauer","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189697_bb0095","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2741\/3738","article-title":"Myb proteins: angels and demons in normal and transformed cells","volume":"16","author":"Zhou","year":"2011","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41389-021-00309-y","article-title":"MYB oncoproteins: emerging players and potential therapeutic targets in human cancer","volume":"10","author":"Cicir\u00f2","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbcan.2026.189697_bb0105","first-page":"7334","article-title":"Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo","volume":"13","author":"Dini","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0110","doi-asserted-by":"crossref","first-page":"17067","DOI":"10.1073\/pnas.1012402107","article-title":"The C-MYB story - is it definitive?","volume":"107","author":"Lipsick","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189697_bb0115","doi-asserted-by":"crossref","first-page":"11075","DOI":"10.1093\/nar\/16.23.11075","article-title":"Isolation of human cDNA clones of myb -related genes, A- myb and B- myb","volume":"16","author":"Nomura","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0120","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1101\/gad.13.9.1073","article-title":"c-Myb is essential for early T cell development","volume":"13","author":"Allen","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2026.189697_bb0125","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1073\/pnas.0610055104","article-title":"c-Myb is required for progenitor cell homeostasis in colonic crypts","volume":"104","author":"Malaterre","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1634\/stemcells.2007-0293","article-title":"C-Myb is required for neural progenitor cell proliferation and maintenance of the neural stem cell niche in adult brain","volume":"26","author":"Malaterre","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbcan.2026.189697_bb0135","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1242\/dev.067645","article-title":"A-MYB (MYBL1) transcription factor is a master regulator of male meiosis","volume":"138","author":"Bolcun-Filas","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.bbcan.2026.189697_bb0140","first-page":"1161","article-title":"Temporal patterns of A-myb and B-myb gene expression during testis development","volume":"13","author":"Latham","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0145","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1002\/j.1460-2075.1994.tb06945.x","article-title":"Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes","volume":"13","author":"Trauth","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2026.189697_bb0150","doi-asserted-by":"crossref","first-page":"e2895","DOI":"10.1038\/cddis.2017.244","article-title":"MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis","volume":"8","author":"Musa","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189697_bb0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/nar\/gky935","article-title":"Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis\/trans isomerization","volume":"47","author":"Werwein","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3892\/ol.2021.12427","article-title":"Association between B- Myb proto-oncogene and the development of malignant tumors (review)","volume":"21","author":"Jin","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2026.189697_bb0165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0960-9822(06)00121-7","article-title":"Phosphorylation and activation of B-Myb by cyclin A\u2013Cdk2","volume":"7","author":"Ziebold","year":"1997","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0170","doi-asserted-by":"crossref","first-page":"12543","DOI":"10.1093\/nar\/gkac1102","article-title":"Structural basis of transcription regulation by CNC family transcription factor, Nrf2","volume":"50","author":"Sengoku","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0175","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1073\/pnas.89.7.3088","article-title":"Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure","volume":"89","author":"Kanei-Ishii","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0180","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1093\/nar\/29.17.3546","article-title":"The highly conserved DNA-binding domains of A-, B- and c-Myb differ with respect to DNA-binding, phosphorylation and redox properties","volume":"29","author":"Bergholtz","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0185","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/335835a0","article-title":"Viral myb oncogene encodes a sequence-specific DNA-binding activity","volume":"335","author":"Biedenkapp","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189697_bb0190","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1006\/bcmd.2001.0405","article-title":"The conserved DNA binding domain mediates similar regulatory interactions for A-Myb, B-Myb, and c-Myb transcription factors","volume":"27","author":"Rushton","year":"2001","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbcan.2026.189697_bb0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2012.12.009","article-title":"DNA-binding specificities of human transcription factors","volume":"152","author":"Jolma","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189697_bb0200","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz1081","article-title":"Structural insights into target DNA recognition by R2R3-MYB transcription factors","author":"Wang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102319","article-title":"Cyclin-dependent kinase-mediated phosphorylation and the negative regulatory domain of transcription factor B-Myb modulate its DNA binding","volume":"298","author":"Wijeratne","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189697_bb0210","first-page":"1855","article-title":"Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle","volume":"12","author":"Robinson","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0215","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1073\/pnas.94.2.532","article-title":"Activation of human B-MYB by cyclins","volume":"94","author":"Sala","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189697_bb0220","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.onc.1201282","article-title":"Linking Myb to the cell cycle: cyclin-dependent phosphorylation and regulation of A-Myb activity","volume":"15","author":"Ziebold","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0225","author":"Tomita"},{"key":"10.1016\/j.bbcan.2026.189697_bb0230","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/bloodadvances.2021005955","article-title":"Myb drives B-cell neoplasms and myeloid malignancies in vivo","volume":"6","author":"Pieters","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.bbcan.2026.189697_bb0235","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/j.1460-2075.1989.tb03571.x","article-title":"Activation of c-myb by carboxy-terminal truncation: relationship to transformation of murine haemopoietic cells in vitro","volume":"8","author":"Gonda","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2026.189697_bb0240","first-page":"2451","article-title":"Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction","volume":"59","author":"Grassilli","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0245","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/onc.2009.22","article-title":"A Lin-9 complex is recruited by B-Myb to activate transcription of G2\/M genes in undifferentiated embryonal carcinoma cells","volume":"28","author":"Knight","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0250","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.bbagrm.2012.03.008","article-title":"Binding of FoxM1 to G2\/M gene promoters is dependent upon B-Myb","volume":"1819","author":"Down","year":"2012","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.bbcan.2026.189697_bb0255","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1093\/nar\/gkr024","article-title":"Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb","volume":"39","author":"Zhao","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0260","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/stem.496","article-title":"B-Myb is critical for proper DNA duplication during an unperturbed S phase in mouse embryonic stem cells","volume":"28","author":"Lorvellec","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbcan.2026.189697_bb0265","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/jcp.22399","article-title":"MYBL2, a link between proliferation and differentiation in maturing colon epithelial cells","volume":"226","author":"Papetti","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0270","first-page":"1233","article-title":"Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products","volume":"7","author":"Nakagoshi","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0275","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.bbrc.2006.04.045","article-title":"DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein","volume":"344","author":"Lutwyche","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2026.189697_bb0280","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/10409238.2017.1360836","article-title":"Cell cycle transcription control: DREAM\/MuvB and RB-E2F complexes","volume":"52","author":"Fischer","year":"2017","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0285","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.ejca.2005.08.004","article-title":"B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer","volume":"41","author":"Sala","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189697_bb0290","doi-asserted-by":"crossref","first-page":"28067","DOI":"10.1074\/jbc.274.40.28067","article-title":"B-myb is required for inner cell mass formation at an early stage of development","volume":"274","author":"Tanaka","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189697_bb0295","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051120","article-title":"MYBL2 and ATM suppress replication stress in pluripotent stem cells","volume":"22","author":"Blakemore","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbcan.2026.189697_bb0300","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/mc.20147","article-title":"Co-regulation of B-Myb expression by E2F1 and EGF receptor","volume":"45","author":"Hanada","year":"2006","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbcan.2026.189697_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.637193","article-title":"Oncogenic B-Myb is associated with deregulation of the DREAM-mediated cell cycle gene expression program in high grade serous ovarian carcinoma clinical tumor samples","volume":"11","author":"Iness","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0310","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41388-018-0490-y","article-title":"The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb","volume":"38","author":"Iness","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0315","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1038\/s41388-021-01961-9","article-title":"B-Myb accelerates colorectal cancer progression through reciprocal feed-forward transactivation of E2F2","volume":"40","author":"Fan","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0320","first-page":"1825","article-title":"Elevated expression of the MYB proto-oncogene like 2 (MYBL2)-encoding gene as a prognostic and predictive biomarker in human cancers","volume":"19","author":"Xin","year":"2022","journal-title":"Math. Biosci. Eng."},{"key":"10.1016\/j.bbcan.2026.189697_bb0325","first-page":"27","article-title":"High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma","volume":"66","author":"Guan","year":"2018","journal-title":"Curr. Res. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189697_bb0330","doi-asserted-by":"crossref","DOI":"10.4081\/ejh.2021.3226","article-title":"Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma","volume":"65","author":"Le","year":"2021","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.bbcan.2026.189697_bb0335","first-page":"2765","article-title":"Upregulation of MYBL2 independently predicts a poorer prognosis in patients with clear cell renal cell carcinoma","volume":"19","author":"Sun","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2026.189697_bb0340","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.7150\/thno.56604","article-title":"MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189697_bb0345","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1080\/15384101.2021.1982494","article-title":"Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogene","volume":"20","author":"Chen","year":"2021","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2026.189697_bb0350","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10549-011-1600-5","article-title":"Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome","volume":"130","author":"Shi","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2026.189697_bb0355","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/onc.2008.430","article-title":"In vitro and in vivo analysis of B-Myb in basal-like breast cancer","volume":"28","author":"Thorner","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0360","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/ijms26010322","article-title":"Emerging role of the DREAM complex in cancer and therapeutic opportunities","volume":"26","author":"Hwang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0365","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc3556","article-title":"The DREAM complex: master coordinator of cell cycle-dependent gene expression","volume":"13","author":"Sadasivam","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189697_bb0370","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.tibs.2022.06.007","article-title":"Coordinating gene expression during the cell cycle","volume":"47","author":"Fischer","year":"2022","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0375","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1002\/j.1460-2075.1993.tb05932.x","article-title":"An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription","volume":"12","author":"Lam","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2026.189697_bb0380","doi-asserted-by":"crossref","first-page":"97736","DOI":"10.18632\/oncotarget.10888","article-title":"Timing of transcription during the cell cycle: protein complexes binding to E2F, E2F\/CLE, CDE\/CHR, or CHR promoter elements define early and late cell cycle gene expression","volume":"8","author":"M\u00fcller","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189697_bb0385","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/nar\/gkr793","article-title":"The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes","volume":"40","author":"M\u00fcller","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0390","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1101\/gad.2034211","article-title":"DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly","volume":"25","author":"Litovchick","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2026.189697_bb0395","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1101\/gad.257568.114","article-title":"Structural mechanisms of DREAM complex assembly and regulation","volume":"29","author":"Guiley","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2026.189697_bb0400","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41594-023-00942-8","article-title":"The DREAM complex functions as conserved master regulator of somatic DNA-repair capacities","volume":"30","author":"Bujarrabal-Dueso","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0405","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/s12935-021-02362-4","article-title":"Intricate crosstalk between MYB and noncoding RNAs in cancer","volume":"21","author":"Hu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2026.189697_bb0410","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1756-9966-32-98","article-title":"The inhibitory role of Mir-29 in growth of breast cancer cells","volume":"32","author":"Wu","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0415","doi-asserted-by":"crossref","DOI":"10.1095\/biolreprod.114.121988","article-title":"Functional analysis of miR-34c as a putative tumor suppressor in high-grade serous ovarian cancer","volume":"91","author":"Yu","year":"2014","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.bbcan.2026.189697_bb0420","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.leukres.2013.09.015","article-title":"Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients","volume":"37","author":"Fuster","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0425","first-page":"G508","article-title":"Mybl2, downregulated during colon epithelial cell maturation, is suppressed by miR-365","volume":"301","author":"Papetti","year":"2011","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0430","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1158\/1078-0432.CCR-10-3244","article-title":"miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells","volume":"17","author":"Zauli","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0435","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1158\/0008-5472.CAN-11-1044","article-title":"B-Myb, cancer, senescence, and microRNAs","volume":"71","author":"Martinez","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0440","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1074\/jbc.M105112200","article-title":"Effects of B-Myb on gene transcription","volume":"277","author":"Johnson","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189697_bb0445","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/sj.onc.1207255","article-title":"The cooperation of B-Myb with the coactivator p300 is orchestrated by cyclins A and D1","volume":"23","author":"Schubert","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138588","article-title":"MYB proteins: versatile regulators of plant development, stress responses, and secondary metabolite biosynthetic pathways","volume":"288","author":"Bhatt","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0455","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1158\/0008-5472.CAN-18-0273","article-title":"MYBL2 supports DNA double strand break repair in hematopoietic stem cells","volume":"78","author":"Bayley","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042350","article-title":"The B-MYB transcriptional network guides cell cycle progression and fate decisions to sustain self-renewal and the identity of pluripotent stem cells","volume":"7","author":"Zhan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189697_bb0465","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1093\/nar\/gkae370","article-title":"A-MYB substitutes for B-MYB in activating cell cycle genes and in stimulating proliferation","volume":"52","author":"Kohler","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0470","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1101\/gad.181933.111","article-title":"The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression","volume":"26","author":"Sadasivam","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2026.189697_bb0475","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.celrep.2019.05.071","article-title":"The Myb-MuvB complex is required for YAP-dependent transcription of mitotic genes","volume":"27","author":"Pattschull","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189697_bb0480","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1111\/j.1742-4658.2009.07261.x","article-title":"LIN54 is an essential core subunit of the DREAM\/LINC complex that binds to the cdc2 promoter in a sequence-specific manner","volume":"276","author":"Schmit","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.bbcan.2026.189697_bb0485","doi-asserted-by":"crossref","first-page":"12301","DOI":"10.1038\/ncomms12301","article-title":"Structural basis for LIN54 recognition of CHR elements in cell cycle-regulated promoters","volume":"7","author":"Marceau","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189697_bb0490","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1038\/s41467-022-32798-9","article-title":"Structure of a nucleosome-bound MuvB transcription factor complex reveals DNA remodelling","volume":"13","author":"Koliopoulos","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189697_bb0495","series-title":"B-MYB and FOXM1 Drive Cell Division Through Cooperative Regulation of Cell Cycle Genes","author":"Rivas","year":"2023"},{"key":"10.1016\/j.bbcan.2026.189697_bb0500","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1093\/nar\/gku696","article-title":"The CHR site: definition and genome-wide identification of a cell cycle transcriptional element","volume":"42","author":"M\u00fcller","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0505","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/MCB.00881-12","article-title":"The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism","volume":"33","author":"Chen","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0510","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1093\/nar\/gkq194","article-title":"Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence","volume":"38","author":"Littler","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0515","doi-asserted-by":"crossref","first-page":"11160","DOI":"10.18632\/oncotarget.14466","article-title":"Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy","volume":"8","author":"Wolter","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189697_bb0520","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.7150\/ijbs.92607","article-title":"Genome-wide binding analysis unveils critical implication of B-Myb-mediated transactivation in cancers","volume":"20","author":"Tao","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0525","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/nar\/gkv927","article-title":"The p53-p21-DREAM-CDE\/CHR pathway regulates G 2 \/M cell cycle genes","volume":"44","author":"Fischer","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0530","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/onc.2016.181","article-title":"An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma","volume":"36","author":"Iltzsche","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002478","article-title":"B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells","volume":"3","author":"Tarasov","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189697_bb0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008818","article-title":"Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes","volume":"16","author":"Gr\u00fcndl","year":"2020","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbcan.2026.189697_bb0545","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1093\/nar\/gkad107","article-title":"Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration","volume":"51","author":"Fetiva","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0550","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1242\/jcs.02870","article-title":"The transcription factor B-Myb is essential for S-phase progression and genomic stability in diploid and polyploid megakaryocytes","volume":"119","author":"Garc\u00eda","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188407","article-title":"MYBL2 amplification in breast cancer: molecular mechanisms and therapeutic potential","volume":"1874","author":"Bayley","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189697_bb0560","doi-asserted-by":"crossref","first-page":"535","DOI":"10.18632\/oncotarget.498","article-title":"A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB\/MYCN axis in neuroblastoma","volume":"3","author":"Sottile","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189697_bb0565","doi-asserted-by":"crossref","first-page":"278","DOI":"10.18632\/oncotarget.138","article-title":"Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loop","volume":"1","author":"Gualdrini","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189697_bb0570","doi-asserted-by":"crossref","first-page":"21506","DOI":"10.1038\/s41598-021-01012-z","article-title":"Simultaneous expression of MMB-FOXM1 complex components enables efficient bypass of senescence","volume":"11","author":"Kumari","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189697_bb0575","doi-asserted-by":"crossref","first-page":"443","DOI":"10.21037\/atm.2018.09.62","article-title":"Transcription regulation of MYB: a potential and novel therapeutic target in cancer","volume":"6","author":"Mitra","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189697_bb0580","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1073\/pnas.1017346108","article-title":"miR-29 and miR-30 regulate B-Myb expression during cellular senescence","volume":"108","author":"Martinez","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0585","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1002\/1878-0261.13314","article-title":"Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer","volume":"16","author":"Yoshikawa","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132244","article-title":"G-quadruplex forming motifs in the promoter region of the B-MYB proto-oncogene","volume":"270","author":"Miranda","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0595","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/MCB.00067-16","article-title":"Parallel regulation of von Hippel-Lindau disease by pVHL-mediated degradation of B-Myb and hypoxia-inducible factor \u03b1","volume":"36","author":"Okumura","year":"2016","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0600","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bcmd.2007.04.006","article-title":"B-MYB is hypophosphorylated and resistant to degradation in neuroblastoma: implications for cell survival","volume":"39","author":"Schwab","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbcan.2026.189697_bb0605","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.7150\/ijbs.72386","article-title":"E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry","volume":"18","author":"Du","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0610","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12935-023-03079-2","article-title":"The MYBL2\u2013CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages","volume":"23","author":"Pan","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2026.189697_bb0615","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1038\/s41598-025-93022-4","article-title":"MYBL2 promotes cell proliferation and inhibits cell apoptosis via PI3K\/AKT and BCL2\/BAX\/Cleaved-caspase-3 signaling pathway in gastric cancer cells","volume":"15","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189697_bb0620","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1002\/1873-3468.13940","article-title":"Intramolecular interaction of B-MYB is regulated through Ser-577 phosphorylation","volume":"594","author":"Werwein","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbcan.2026.189697_bb0625","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/sj.onc.1203618","article-title":"Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCFp45Skp2 pathway","volume":"19","author":"Charrasse","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108808","article-title":"MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity","volume":"34","author":"Branigan","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189697_bb0635","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1091\/mbc.e13-05-0264","article-title":"Identification of cell cycle\u2013regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors","volume":"24","author":"Grant","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbcan.2026.189697_bb0640","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1038\/onc.2013.426","article-title":"A functional interaction of E7 with B-Myb-MuvB complex promotes acute cooperative transcriptional activation of both S- and M-phase genes. (129 c)","volume":"33","author":"Pang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0645","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/path.4321","article-title":"Effects of <scp>TP53<\/scp> mutational status on gene expression patterns across 10 human cancer types","volume":"232","author":"Parikh","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0650","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0655","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-14-0816","article-title":"Molecular pathways: targeting the Cyclin D\u2013CDK4\/6 axis for cancer treatment","volume":"21","author":"VanArsdale","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0660","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/ijms19051479","article-title":"B-Myb mediates proliferation and migration of non-small-cell lung cancer via suppressing IGFBP3","volume":"19","author":"Fan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0665","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.585551","article-title":"MYBL2-driven transcriptional programs link replication stress and error-prone DNA repair with genomic instability in lung adenocarcinoma","volume":"10","author":"Morris","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0670","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/emboj.2008.118","article-title":"A B-Myb complex containing clathrin and filamin is required for mitotic spindle function","volume":"27","author":"Yamauchi","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2026.189697_bb0675","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1209136","article-title":"Whole-genome doubling as a source of cancer: how, when, where, and why?","volume":"11","author":"Sanz-G\u00f3mez","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0680","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.celrep.2018.04.102","article-title":"Identification of drivers of aneuploidy in breast tumors","volume":"23","author":"Pfister","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189697_bb0685","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/nar\/24.15.2905","article-title":"Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element","volume":"24","author":"Liu","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0690","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.4161\/cc.22386","article-title":"B-Myb promotes S-phase independently of its sequence-specific DNA binding activity and interacts with polymerase delta-interacting protein 1 (Pdip1)","volume":"11","author":"Werwein","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2026.189697_bb0695","doi-asserted-by":"crossref","first-page":"41663","DOI":"10.1038\/srep41663","article-title":"Interplay with the Mre11-Rad50-Nbs1 complex and phosphorylation by GSK3\u03b2 implicate human B-Myb in DNA-damage signaling","volume":"7","author":"Henrich","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189697_bb0700","doi-asserted-by":"crossref","first-page":"21055","DOI":"10.1074\/jbc.M002055200","article-title":"Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB","volume":"275","author":"Cervellera","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189697_bb0705","doi-asserted-by":"crossref","first-page":"15628","DOI":"10.1074\/jbc.M411747200","article-title":"Temperature-dependent modification and activation of B-MYB","volume":"280","author":"Santilli","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189697_bb0710","article-title":"Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration","volume":"11","author":"Qiu","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbcan.2026.189697_bb0715","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2567.2004.02073.x","article-title":"A transcriptional regulatory element in the coding sequence of the human Bcl -2 gene","volume":"114","author":"Lang","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.bbcan.2026.189697_bb0720","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1074\/jbc.M110.184382","article-title":"B-MYB positively regulates serine-threonine kinase receptor-associated protein (STRAP) activity through direct interaction","volume":"286","author":"Seong","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189697_bb0725","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0730","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12032-014-0412-y","article-title":"B-Myb regulates snail expression to promote epithelial-to-mesenchymal transition and invasion of breast cancer cell","volume":"32","author":"Tao","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0735","first-page":"1960","article-title":"MYBL2 accelerates epithelial-mesenchymal transition and hepatoblastoma metastasis via the Smad\/SNAI1 pathway","volume":"12","author":"Wei","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0740","first-page":"1542","article-title":"MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer","volume":"5","author":"Ren","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.816070","article-title":"Downstream regulatory network of MYBL2 mediating its oncogenic role in melanoma","volume":"12","author":"Zhong","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0750","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1080\/21655979.2022.2056821","article-title":"Actin-binding Rho activating C-terminal like (ABRACL) transcriptionally regulated by MYB proto-oncogene like 2 (MYBL2) promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of breast cancer cells","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbcan.2026.189697_bb0755","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1080\/21655979.2021.2017630","article-title":"MYB proto-oncogene like 2 promotes hepatocellular carcinoma growth and glycolysis via binding to the Optic atrophy 3 promoter and activating its expression","volume":"13","author":"Liu","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbcan.2026.189697_bb0760","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-10354-4","article-title":"MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2026.189697_bb0765","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8693259","article-title":"LncRNA-MALAT1 regulates cancer glucose metabolism in prostate cancer via MYBL2\/mTOR Axis","volume":"2022","author":"Mu","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbcan.2026.189697_bb0770","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.7150\/jca.107232","article-title":"System analysis identifies MYBL2 as a novel oncogene target for metastatic prostate cancer","volume":"16","author":"Huang","year":"2025","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189697_bb0775","article-title":"The oncogene MYBL2 promotes the malignant phenotype and suppresses apoptosis through hedgehog signaling pathway in clear cell renal cell carcinoma","volume":"10","author":"Yang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbcan.2026.189697_bb0780","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1158\/1078-0432.CCR-05-2339","article-title":"Prognosis and gene expression profiling of 20q13-amplified breast cancers","volume":"12","author":"Ginestier","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0785","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10735-020-09920-6","article-title":"The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer","volume":"52","author":"Li","year":"2021","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0790","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-05674-7","article-title":"Notch3 regulates Mybl2 via HeyL to limit proliferation and tumor initiation in breast cancer","volume":"14","author":"Brahim","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189697_bb0795","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-02956-6","article-title":"MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54","volume":"19","author":"Liu","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189697_bb0800","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.7150\/jca.96320","article-title":"MYBL2 is a novel independent prognostic biomarker and correlated with TMB in pancreatic cancer","volume":"15","author":"Li","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189697_bb0805","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.prp.2017.04.024","article-title":"Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma","volume":"213","author":"Yu","year":"2017","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbcan.2026.189697_bb0810","first-page":"389","article-title":"CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer","volume":"11","author":"Qi","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0815","doi-asserted-by":"crossref","first-page":"21126","DOI":"10.1002\/jcp.28715","article-title":"Modulation of Myb-induced NF-kB -STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors","volume":"234","author":"Tian","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0820","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.3390\/cancers14204979","article-title":"Characterizing and targeting genes regulated by transcription factor MYBL2 in lung adenocarcinoma cells","volume":"14","author":"Lee","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189697_bb0825","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/onc.2012.90","article-title":"Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor","volume":"32","author":"Iida","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0830","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40001-025-03648-3","article-title":"MYBL2 regulates the expression of CENPF in lung adenocarcinoma and promotes tumor development and metastasis through AKT pathway activation","volume":"31","author":"Liu","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108027","article-title":"E2F1 and E2F7 regulate gastric cancer cell proliferation, respectively, through transcriptional activation and transcriptional repression of MYBL2","volume":"301","author":"Wu","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189697_bb0840","doi-asserted-by":"crossref","first-page":"957","DOI":"10.17219\/acem\/135938","article-title":"MYBL2 in synergy with CDC20 promotes the proliferation and inhibits apoptosis of gastric cancer cells","volume":"30","author":"Deng","year":"2021","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189697_bb0845","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1038\/s41388-022-02456-x","article-title":"MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3","volume":"41","author":"Liu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189697_bb0850","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401910R","article-title":"MYBL2 promotes proliferation of clear cell renal cell carcinoma by regulating TOP2A and activating AKT\/mTOR signaling pathway","volume":"39","author":"Huang","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2026.189697_bb0855","doi-asserted-by":"crossref","first-page":"595","DOI":"10.56434\/j.arch.esp.urol.20257805.80","article-title":"MYB proto-oncogene like 2 promotes the growth of renal carcinoma by attenuating endoplasmic reticulum stress and activating lipid rafts","volume":"78","author":"Zhang","year":"2025","journal-title":"Arch. Esp. Urol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0860","article-title":"The correlation between the MYBL2\/CDCA8 signaling pathway of malignant melanoma","volume":"10","author":"Wu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbcan.2026.189697_bb0865","article-title":"MYBL2 alternative splicing-related genetic variants reduce the risk of triple-negative breast cancer in the Chinese population","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Genet."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189697_bb0870","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/s41418-021-00823-x","article-title":"Ki-67 gene expression","volume":"28","author":"Uxa","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2026.189697_bb0875","first-page":"1833","article-title":"Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer","volume":"6","author":"Tanner","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0880","first-page":"16","article-title":"Prognostic value of topoisomerase 2-alpha and B-Myb in early breast cancer treated with adjuvant chemotherapy","volume":"60","author":"Varga","year":"2021","journal-title":"Acta Clin. Croat."},{"key":"10.1016\/j.bbcan.2026.189697_bb0885","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/gcc.10122","article-title":"Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer","volume":"35","author":"Mahlam\u00e4ki","year":"2002","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.bbcan.2026.189697_bb0890","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014632","article-title":"Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer","volume":"6","author":"Tabach","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189697_bb0895","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213684","article-title":"Genome-wide CRISPR screen identifies genes involved in metastasis of pancreatic ductal adenocarcinoma","volume":"16","author":"Oktriani","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189697_bb0900","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1438198","article-title":"Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer","volume":"15","author":"Shao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0905","article-title":"Identification of aberrantly methylated differentially expressed genes and pro-tumorigenic role of KIF2C in melanoma","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbcan.2026.189697_bb0910","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11010-020-03721-x","article-title":"Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH","volume":"468","author":"Xiong","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2026.189697_bb0915","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2906204","article-title":"DEPDC1B is a novel direct target of B-Myb and contributes to malignant progression and immune infiltration in lung adenocarcinoma","volume":"29","author":"Zuo","year":"2024","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.bbcan.2026.189697_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.103016","article-title":"Helicobacter pylori infection induces STAT3\/MYBL2\/NF-\u03baB axis to promote gastric cancer progression","volume":"96","author":"Feng","year":"2025","journal-title":"Tissue Cell"},{"key":"10.1016\/j.bbcan.2026.189697_bb0925","article-title":"Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance","volume":"18","author":"Long","year":"2023","journal-title":"Open Med. (Wars)"},{"key":"10.1016\/j.bbcan.2026.189697_bb0930","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1158\/2767-9764.CRC-24-0069","article-title":"MYBL2 drives prostate cancer plasticity: inhibiting its transcriptional target CDK2 for RB1-deficient neuroendocrine prostate cancer","volume":"4","author":"German","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.bbcan.2026.189697_bb0935","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00432-020-03392-7","article-title":"B-MYB\u2014p53-related relevant regulator for the progression of clear cell renal cell carcinoma","volume":"147","author":"Nientiedt","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110412","article-title":"Transcription factor B-MYB activates lncRNA CCAT1 and upregulates SOCS3 to promote chemoresistance in colorectal cancer","volume":"374","author":"Liu","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbcan.2026.189697_bb0945","article-title":"MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer","author":"German","year":"2024","journal-title":"BioRxiv"},{"key":"10.1016\/j.bbcan.2026.189697_bb0950","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1158\/0008-5472.CAN-08-4156","article-title":"B-MYB is required for recovery from the DNA damage\u2013induced G2 checkpoint in p53 mutant cells","volume":"69","author":"Mannefeld","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb0955","series-title":"MYBL2 Maintains Stemness and Promotes Theta-Mediated End Joining in Triple Negative Breast Cancer","author":"Bayley","year":"2025"},{"key":"10.1016\/j.bbcan.2026.189697_bb0960","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.2147\/IJGM.S351638","article-title":"MYBL2 is a novel independent prognostic biomarker and correlated with immune infiltrates in prostate cancer","volume":"15","author":"Jiao","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.bbcan.2026.189697_bb0965","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1304342","article-title":"Antisense oligonucleotides: a novel Frontier in pharmacological strategy","volume":"14","author":"Collotta","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189697_bb0970","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43856-023-00419-1","article-title":"Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders","volume":"4","author":"Lauffer","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.bbcan.2026.189697_bb0975","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymthe.2024.01.005","article-title":"The landscape of nanoparticle-based siRNA delivery and therapeutic development","volume":"32","author":"Moazzam","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2026.189697_bb0980","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41392-024-02035-4","article-title":"Nucleic acid drugs: recent progress and future perspectives","volume":"9","author":"Sun","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189697_bb0985","doi-asserted-by":"crossref","first-page":"10415","DOI":"10.1073\/pnas.89.21.10415","article-title":"Regulation of BALB\/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression","volume":"89","author":"Sala","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0990","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1073\/pnas.0534764100","article-title":"Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth","volume":"100","author":"Leong","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102268","article-title":"Bi-functional CpG-STAT3 decoy oligonucleotide triggers multilineage differentiation of acute myeloid leukemia in mice","volume":"35","author":"Wang","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbcan.2026.189697_bb1000","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3390\/ijms23042097","article-title":"Targeting KRAS regulation with PolyPurine Reverse Hoogsteen oligonucleotides","volume":"23","author":"Psaras","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb1005","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/ijms24010378","article-title":"Targeting MYC regulation with Polypurine reverse Hoogsteen oligonucleotides","volume":"24","author":"Valiuska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb1010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.tips.2025.02.009","article-title":"CRISPR\/Cas technologies for cancer drug discovery and treatment","volume":"46","author":"Wang","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2026.189697_bb1015","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nmeth.3630","article-title":"Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements","volume":"12","author":"Thakore","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbcan.2026.189697_bb1020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-scale CRISPR-mediated control of gene repression and activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189697_bb1025","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1038\/s41467-021-24198-2","article-title":"Promoter G-quadruplexes and transcription factors cooperate to shape the cell type-specific transcriptome","volume":"12","author":"Lago","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189697_bb1030","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.3390\/molecules26206164","article-title":"Ligands as stabilizers of G-quadruplexes in non-coding RNAs","volume":"26","author":"Figueiredo","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bbcan.2026.189697_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131055","article-title":"Targeting proto-oncogene B-MYB G-quadruplex with a nucleic acid\u2013based fluorescent probe","volume":"266","author":"Louren\u00e7o","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2026.189697_bb1040","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41556-024-01448-1","article-title":"Targeting specific DNA G-quadruplexes with CRISPR-guided G-quadruplex-binding proteins and ligands","volume":"26","author":"Qin","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189697_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139582","article-title":"I-motif formation in the promoter region of the B-MYB proto-oncogene","volume":"296","author":"Alves","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2026.189697_bb1050","doi-asserted-by":"crossref","first-page":"12020","DOI":"10.1093\/nar\/gkad981","article-title":"Decoding complexity in biomolecular recognition of DNA i-motifs with microarrays","volume":"51","author":"Yazdani","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb1055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s42004-024-01387-w","article-title":"Modulation of Nrf2 expression by targeting i-motif DNA","volume":"8","author":"Warner","year":"2025","journal-title":"Commun. Chem."},{"key":"10.1016\/j.bbcan.2026.189697_bb1060","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41598-021-04497-w","article-title":"Rational design of a helical peptide inhibitor targeting c-Myb\u2013KIX interaction","volume":"12","author":"Suetaka","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189697_bb1065","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41591-024-02805-1","article-title":"MYC targeting by OMO-103 in solid tumors: a phase 1 trial","volume":"30","author":"Garralda","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189697_bb1070","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","article-title":"Targeting transcription factors in cancer \u2014 from undruggable to reality","volume":"19","author":"Bushweller","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189697_bb1075","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1021\/acs.jmedchem.4c01009","article-title":"Discovery of AK-1690: a potent and highly selective STAT6 PROTAC degrader","volume":"68","author":"Kaneshige","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2026.189697_bb1080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13046-022-02483-2","article-title":"Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression","volume":"41","author":"Wang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189697_bb1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108626","article-title":"A novel designed fully peptide-based PROTAC, FPP29, demonstrates its potent cytotoxic effects to liver cancer HCCLM3 cells by targeting FOXM1","volume":"163","author":"Jia","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbcan.2026.189697_bb1090","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202300594","article-title":"Double stranded DNA binding stapled peptides: an emerging tool for transcriptional regulation","volume":"24","author":"Paquette","year":"2023","journal-title":"ChemBioChem"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:22:36Z","timestamp":1789518156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":218,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0304419X26001691"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189697","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-MYB (MYBL2): from cell cycle regulator to an oncogenic player","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189697"}}